Literature DB >> 27008896

Blood transfusion services for patients with sickle cell disease in Nigeria.

Ijeoma N Diaku-Akinwumi1, Sani B Abubakar2, Samuel A Adegoke3, Solomon Adeleke4, Oyebade Adewoye5, Titilayo Adeyemo6, Akinsegun Akinbami7, Norah O Akinola8, Adebola Akinsulie9, Adeline Akinyoola10, John Aneke11, Sani Awwalu12, Ahmadu Babadoko12, Biobele Brown13, Obuoha Ejike14, Ifeoma Emodi15, Innocent George16, Ahmed Girei17, Abdulaziz Hassan12, Garba U Kangiwa18, Olubunmi A Lawal19, Cecilia Mabogunje20, Anazoeze J Madu21, Akeem Mustapha22, Muhammad Ndakotsu2, Obiageli E Nnodu4, Damian Nwaneri23, Friday Odey F24, Chinatu Ohiaeri25, Rasaq Olaosebikan26, Oladele S Olatunya O27, Oluseyi Oniyangi28, Hyginus Opara29, Ngozi I Ugwu30, Abubakar U Musa2, Shehu Abdullahi31, Abubakar Usman32, Enobong Utuk33, Binta W Jibir34, Adekunle D Adekile35.   

Abstract

BACKGROUND: Safe, timely red blood cell transfusion saves lives and chronic transfusion therapy (CTT) prevents or limits morbidities such as stroke, therefore improving quality of life of patients with sickle cell disease (SCD).
METHODS: This questionnaire-based study assessed the ability of sickle cell centers in Nigeria to provide safe blood to patients with SCD between March and August 2014.
RESULTS: Out of the 73 hospitals contacted, responses were obtained from 31. Twenty four (78%) hospitals were unable to transfuse patients regularly due to blood scarcity. Packed red blood cells were available in 14 (45%), while only one provided leukocyte-depletion. Most centers assessed donor risk and screened for HIV in 30 (97%), hepatitis B in 31(100%) and hepatitis C in 27 (87%) hospitals. Extended phenotyping and alloantibody screening were not available in any center. A quarter of the hospitals could monitor iron overload, but only using serum ferritin. Access to iron chelators was limited and expensive. Seventeen (55%) tertiary hospitals offered CTT by top-up or manual exchange transfusion; previous stroke was the most common indication.
CONCLUSION: Current efforts of Nigerian public hospitals to provide safe blood and CTT fall short of best practice. Provision of apheresis machines, improvement of voluntary non-remunerated donor drive, screening for red cell antigens and antibodies, and availability of iron chelators would significantly improve SCD care in Nigeria.
© The Author 2016. Published by Oxford University Press on behalf of Royal Society of Tropical Medicine and Hygiene. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Blood transfusion; Nigeria; Sickle cell disease

Mesh:

Year:  2016        PMID: 27008896     DOI: 10.1093/inthealth/ihw014

Source DB:  PubMed          Journal:  Int Health        ISSN: 1876-3405            Impact factor:   2.473


  7 in total

1.  Influence of alpha thalassemia on clinical and laboratory parameters among nigerian children with sickle cell anemia.

Authors:  Oladele S Olatunya; Dulcineia M Albuquerque; Adekunle Adekile; Fernando F Costa
Journal:  J Clin Lab Anal       Date:  2018-08-20       Impact factor: 2.352

2.  Determinants of Care-Seeking Practices for Children with Sickle Cell Disease in Ekiti, Southwest Nigeria.

Authors:  Oladele Simeon Olatunya; Adefunke Olarinre Babatola; Adewuyi Temidayo Adeniyi; Olubunmi Adeola Lawal; Alaba Olanrewaju Daramola; Tosin Anthony Agbesanwa; Temitope Olumuyiwa Ojo; Paul Oladapo Ajayi; Adeleke Ajayi Ibijola; Akinwumi Kolawole Komolafe; Adekunle Adekile
Journal:  J Blood Med       Date:  2021-02-25

3.  Uridine diphosphate glucuronosyl transferase 1A (UGT1A1) promoter polymorphism in young patients with sickle cell anaemia: report of the first cohort study from Nigeria.

Authors:  Oladele Simeon Olatunya; Dulcineia Martins Albuquerque; Ganiyu Olusola Akanbi; Olufunso Simisola Aduayi; Adekunle Bamidele Taiwo; Opeyemi Ayodeji Faboya; Tolorunju Segun Kayode; Daniela Pinheiro Leonardo; Adekunle Adekile; Fernando Ferreira Costa
Journal:  BMC Med Genet       Date:  2019-10-16       Impact factor: 2.103

4.  Improving blood transfusion safety in resource-poor countries: a case study of using leucocyte reduced blood in Uganda.

Authors:  Aggrey Dhabangi; Ezra Musisi; Dorothy Kyeyune
Journal:  Afr Health Sci       Date:  2020-06       Impact factor: 0.927

Review 5.  Sickle Cell Disease in Children and Adolescents: A Review of the Historical, Clinical, and Public Health Perspective of Sub-Saharan Africa and Beyond.

Authors:  Walufu Ivan Egesa; Gloria Nakalema; William M Waibi; Munanura Turyasiima; Emmanuel Amuje; Gloria Kiconco; Simon Odoch; Patrick Kumbowi Kumbakulu; Said Abdirashid; Daniel Asiimwe
Journal:  Int J Pediatr       Date:  2022-10-08

6.  Perceptions and Practice of Early Diagnosis of Sickle Cell Disease by Parents and Physicians in a Southwestern State of Nigeria.

Authors:  Oladele Simeon Olatunya; Adefunke Olarinre Babatola; Ezra Olatunde Ogundare; Babatunde Ajayi Olofinbiyi; Olubunmi Adeola Lawal; Jacob Olumuyiwa Awoleke; Olusola Peter Aduloju; Alaba Olanrewaju Daramola; Eyitayo Ebenezer Emmanuel; Oyebanji Anthony Olajuyin; Akinwumi Kolawole Komolafe; Abiola Olukayode Olaleye
Journal:  ScientificWorldJournal       Date:  2020-05-31

7.  HemoTypeSC point-of-care testing shows high sensitivity with alkaline cellulose acetate hemoglobin electrophoresis for screening hemoglobin SS and SC genotypes.

Authors:  Samuel Ademola Adegoke; Oluwatoyin Ibukun Oladimeji; Morenike Agnes Akinlosotu; Alex Ifeoluwa Akinwumi; Kayode Ademola Matthew
Journal:  Hematol Transfus Cell Ther       Date:  2021-01-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.